MCRB

AcronymDefinition
MCRBModified Cramer-RAO Bound
MCRBMoving Chemical Reaction Boundary (chromatography)
MCRBMinor Construction Review Board
MCRBMembrane Cell-Recycle Bioreactor (biochemistry)
References in periodicals archive ?
(Nasdaq: MCRB) is a leading microbiome therapeutics platform company developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome, where the state of bacterial diversity and function is imbalanced.
Therefore, MCRB is adopted to assess performance bound, which is slightly looser than the true CRB, that is,
By comparing Figure 10 with Figure 14, the cavity formed by MCPB was bigger than that formed by MCRB; the same phenomenon can also be found by comparing Figure 11 with Figure 15.
Seres Therapeutics (MCRB) announced a three-year research collaboration with AstraZeneca (AZN).
(NASDAQ: MCRB) is commencing an underwritten registered public offering of USD 60m of shares of its common stock, the company said.
Shaff is executive vice president and chief financial officer of Seres Therapeutics (NASDAQ: MCRB).
Currently, Shaff serves as executive vice president and chief financial officer of Seres Therapeutics (NASDAQ: MCRB),
(NASDAQ: MCRB) has forged a three-year research collaboration with British-Swedish drugmaker AstraZeneca, the company said.
(NASDAQ: MCRB) has made certain corporate changes to focus resources on its highest priority, clinical-stage microbiome therapeutic candidates, the company said.
(NASDAQ: MCRB) has appointed Kevin Horgan, M.D., as executive vice president and chief medical officer, the company said.
- The US Food and Drug Administration has granted Orphan Drug Designation to Cambridge, Massachusetts-based microbiome therapeutics platform company Seres Therapeutics, Inc.'s (NASDAQ: MCRB) microbiome therapeutic candidate SER-287 for the treatment of ulcerative colitis (UC) in pediatric patients, the company said.
(NASDAQ: MCRB) has initiated its Phase 3 SER-109 clinical study (ECOSPOR III) in patients with multiply recurrent C.